These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6424458

  • 1. Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.
    Hill HR, Augustine NH, Shigeoka AO.
    Am J Med; 1984 Mar 30; 76(3A):61-6. PubMed ID: 6424458
    [Abstract] [Full Text] [Related]

  • 2. Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens.
    Hill HR, Bathras JM.
    Rev Infect Dis; 1986 Mar 30; 8 Suppl 4():S396-400. PubMed ID: 3092306
    [Abstract] [Full Text] [Related]

  • 3. Opsonic activity of immunoglobulin prepared for intravenous use.
    Hetherington SV, Giebink GS.
    J Lab Clin Med; 1984 Dec 30; 104(6):977-86. PubMed ID: 6502004
    [Abstract] [Full Text] [Related]

  • 4. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection.
    Bortolussi R, Fischer GW.
    Pediatr Res; 1986 Feb 30; 20(2):175-8. PubMed ID: 3511443
    [Abstract] [Full Text] [Related]

  • 5. Intravenous immunoglobulin in neonatal group B streptococcal disease. Pharmacokinetic and safety studies in monkeys and humans.
    Fischer GW, Weisman LB, Hemming VG, London WT, Hunter KW, Bosworth JM, Sever JL, Wilson SR, Curfman BL.
    Am J Med; 1984 Mar 30; 76(3A):117-23. PubMed ID: 6424443
    [Abstract] [Full Text] [Related]

  • 6. Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo.
    Collins MS, Dorsey JH.
    Am J Med; 1984 Mar 30; 76(3A):155-60. PubMed ID: 6424444
    [Abstract] [Full Text] [Related]

  • 7. Modified human immune serum globulin for intravenous administration: in vitro opsonic activity and in vivo protection against group B streptococcal disease in suckling rats.
    Fischer GW, Hunter KW, Wilson SR.
    Acta Paediatr Scand; 1982 Jul 30; 71(4):639-44. PubMed ID: 6753478
    [Abstract] [Full Text] [Related]

  • 8. A human IgG 3 is opsonic in vitro against type III group B streptococci.
    Kim JS, Kim KS, Wass CA, Short JA, Heiner DC.
    J Clin Immunol; 1990 May 30; 10(3):154-9. PubMed ID: 2195055
    [Abstract] [Full Text] [Related]

  • 9. Antibody levels in reduced/alkylated intravenous immune globulin.
    Rousell RH, Collins MS, Dobkin MB, Louie RE, Roby RE, Sweet BH.
    Am J Med; 1984 Mar 30; 76(3A):40-5. PubMed ID: 6424456
    [Abstract] [Full Text] [Related]

  • 10. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.
    Fischer GW, Wilson SR, Hunter KW.
    J Clin Immunol; 1982 Apr 30; 2(2 Suppl):31S-35S. PubMed ID: 7045156
    [Abstract] [Full Text] [Related]

  • 11. Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use.
    van Furth R, Leijh PC, Klein F.
    J Infect Dis; 1984 Apr 30; 149(4):511-7. PubMed ID: 6202804
    [Abstract] [Full Text] [Related]

  • 12. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND, Munro CS, Cole PJ.
    Clin Exp Immunol; 1989 Apr 30; 76(1):8-12. PubMed ID: 2500275
    [Abstract] [Full Text] [Related]

  • 13. Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection.
    Santos JI, Shigeoka AO, Rote NS, Hill HR.
    J Pediatr; 1981 Dec 30; 99(6):873-9. PubMed ID: 7031210
    [Abstract] [Full Text] [Related]

  • 14. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates.
    Weisman LE, Anthony BF, Hemming VG, Fischer GW.
    J Pediatr; 1993 Jun 30; 122(6):929-37. PubMed ID: 8501574
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy.
    Yang KD, Bathras JM, Shigeoka AO, James J, Pincus SH, Hill HR.
    J Infect Dis; 1989 Apr 30; 159(4):701-7. PubMed ID: 2494269
    [Abstract] [Full Text] [Related]

  • 16. Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum.
    Shaio MF, Yang KD, Bohnsack JF, Hill HR.
    Pediatr Res; 1989 Jun 30; 25(6):634-40. PubMed ID: 2662129
    [Abstract] [Full Text] [Related]

  • 17. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS, Roby RE.
    Am J Med; 1984 Mar 30; 76(3A):168-74. PubMed ID: 6424446
    [Abstract] [Full Text] [Related]

  • 18. Opsonic activity of commercially available standard intravenous immunoglobulin preparations.
    Weisman LE, Cruess DF, Fischer GW.
    Pediatr Infect Dis J; 1994 Dec 30; 13(12):1122-5. PubMed ID: 7892082
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.